SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB:
SEC Accession No. 0001493152-23-028837
Filing Date
2023-08-15
Accepted
2023-08-15 08:26:48
Documents
1
Period of Report
2023-06-30
Effectiveness Date
2023-08-15

Document Format Files

Seq Description Document Type Size
1 formnt10-q.htm NT 10-Q 34272
  Complete submission text file 0001493152-23-028837.txt   35396
Mailing Address 217 W. MAIN STREET SOMERVILLE NJ 08876
Business Address 217 W. MAIN STREET SOMERVILLE NJ 08876 908-370-5102
ZyVersa Therapeutics, Inc. (Filer) CIK: 0001859007 (see all company filings)

IRS No.: 862685744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: NT 10-Q | Act: 34 | File No.: 001-41184 | Film No.: 231173284
SIC: 2834 Pharmaceutical Preparations